Dr Mohammad Radwanur Talukder
MBBS | MPH (KIT, Netherlands) | PhD (Griffith University)
Dr Mohammad Radwanur Talukder has more than 15 years of experience designing and monitoring research projects in both clinical- and community-based settings from Australia and abroad. He worked for and led several community-based intervention trials at the ICDDR (International Centre for Diarrhoeal Disease Research), Bangladesh in collaboration with Johns Hopkins University, Save the Children, UNICEF, International Food Policy Research Institute and the University of Sydney, which led to adaptation of several newborn health intervention strategies both nationally and globally. In 2016, he obtained his PhD in Public Health from Griffith University and joined Baker Heart and Diabetes Institute, Alice Springs in 2017. He is currently managing several community-based and clinical research projects on Human T-cell Leukaemia Virus Type 1 (HTLV-1) in central Australia. In collaboration with the Kirby Institute and Menzies School of Health Research he is now leading the first longitudinal study on HTLV-1 in central Australia. He also has expertise of mixed-method research design, data analyses and interpretation.
Dr Radwan has several publications in international peer reviewed journals including the Lancet. He has also provided scholarly support as a peer reviewer of many high impact journals (including the Lancet Planetary Health, Bulletin of the World Health Organization and Environmental pollution) and is now serving as a Guest Editor for the International Journal of Environmental Research and Public Health (IJERPH). He has received several national and international conference awards including the Young Investigator Awards from the Asia Pacific Society of Hypertension and the High Blood Pressure Research Council, Australia for his PhD research presentation at the 26th Meeting of the International Society of Hypertension in 2016. His research interests include examining the interactions between chronic infections (e.g. HTLV-1), inflammatory processes and chronic diseases, and assessing climate change and health impacts.